newsfilter
← Latest News
PR Newswire·

Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023

– Findings from two clinical study presentations in adults with HRS involving rapid reduction in kidney function1 provide insight into the appropriate use of terlipressin for the care of critically ill